Gliomas - An experience based on molecular markers

BACKGROUND: Gliomas account for 45% of all intracranial tumors. Newer technologies have allowed deeper genetic and epigenetic analysis leading to the discovery of IDH (Isocitrate dehydrogenase) mutations and their association with ATRX (alpha-thalassemia/mental retardation syndrome X-linked) and p53...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarma, Susmita, Khonglah, Yookarin, Mishra, Jaya, Kakati, Arindom, Phukan, Pranjal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140246/
https://www.ncbi.nlm.nih.gov/pubmed/34041176
http://dx.doi.org/10.4103/jfmpc.jfmpc_1963_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140246/
https://www.ncbi.nlm.nih.gov/pubmed/34041176
http://dx.doi.org/10.4103/jfmpc.jfmpc_1963_20

Ejemplares similares